Shanghai INT Medical plans full H-share circulation

Shanghai INT Medical Instruments Co. has announced its intention to implement a full circulation of its H shares. The company submitted a filing to the China Securities Regulatory Commission (CSRC) to convert 71,786,608 domestic shares into H shares and subsequently list them on the Main Board of the Stock Exchange. This initiative aligns with the CSRC’s guidelines for the “Full Circulation” Program for Domestic Unlisted Shares of H-Share Listed Companies.

The conversion and listing are contingent upon obtaining all necessary filings and approvals from relevant regulatory authorities, including the CSRC and the Stock Exchange, and complying with all applicable laws and regulations. The company noted that no general meeting is required to approve this conversion and listing.

As of the announcement date, the specific details of the implementation plan are still being finalized. The company will provide further updates on the progress of the conversion and listing as required by the listing rules. Shareholders and potential investors are advised to exercise caution when trading the company's securities due to the ongoing regulatory processes.